AstraZenecaStudies have shown that the Covid vaccine in Covid is ideal for keeping people away from the hospital and preventing viral deaths.
Only 1.52% of people vaccinated with Oxford vaccine were admitted to the ward after being infected with the virus.
And only 0.03 percent, or 1 in 3,000, died of the disease.
For comparison Pfizer He was hospitalized with the virus and killed 0.15 percent.
The AstraZeneca vaccine forms the backbone of the UK’s vaccine deployment, with 25 million people already receiving jabs.
However, for people under the age of 40 in May, a jab replacement was recommended amid concerns about the disappearance of rare blood clots. Over 21 million people are vaccinated with Pfizer vaccine.
The graph above shows the risk of hospitalization and death after catching Covid between unvaccinated and Pfizer or AstraZeneca vaccinated people.The results show that the AstraZeneca vaccine is best at preventing viral hospitalization and death.
The AstraZeneca vaccine forms the backbone of its deployment in the United Kingdom and is administered to approximately 25 million people. However, in May, alternative jabs were recommended for people under the age of 40 amid concerns about very rare blood clots.
Researchers at Columbia University, based in Bahrain and New York, conducted their research between December and July. Preprint..
They monitored the hospitalizations and deaths of people infected with the virus, unvaccinated people, and those who received jabs in the Middle Eastern island nation of Bahrain.
Studies show that variants of Deltacovid are twice as likely to hospitalize patients
Studies have shown that delta variants double the risk of hospitalization.
The first Covid strain identified in India was already known to be up to 50% more infectious than the previous predominant Alpha mutants that appeared in Kent.
However, the largest study to date comparing the two shows that people infected with the Delta strain are 2.26 times more likely to be hospitalized.
Delta is also 1.45 times more likely to see people entering A & E in need of emergency treatment.
Scientists argued that this is more evidence that the same property of accelerating the spread of the mutant also raises the level of the infected virus, resulting in a more severe virus.
The authors of this study, led by Public Health England and Cambridge University, said the results need to be used by hospitals in planning, especially in areas where Delta variants are increasing.
Dr. Anne Presanis, a senior statistician at the university, said:
“Complete vaccination is important to reduce the risk of individuals with delta-induced symptomatic infections in the first place, and, more importantly, to reduce the risk of serious illness and hospitalization for Delta patients.”
The study also included China National Pharmaceutical and Russian Sputnik jab. Both of these were inferior to European jabs in preventing hospitalization.
For those who received the Sinopharm vaccine, 6.94% were hospitalized and 0.46% died. This was the worst performance of the four vaccines.
Of the Sputnik recipients, 2.24% were hospitalized, but only 0.09% died from the virus.
The results show that unvaccinated people are most likely to be hospitalized or die if infected with the virus.
Of those unvaccinated, 13.22% of those infected with the virus were hospitalized and 1.32% died.
Bahraini researchers said in their study: “All four vaccines reduced the risk of coronavirus infection, hospitalization, ICU admission and death compared to unvaccinated individuals.”
Dr. Simon Clark, a microbiologist at the University of Reading, said: Sun:’This study shows that people in the UK can be confident that they have the best vaccine available.
“AstraZeneca and Pfizer offer excellent protection.”
China’s Sinopharm vaccine is the leading jab used in Bahrain, where about 1.5 million people live.
Over 569,000 people have been vaccinated with jabs.
For comparison, 245,000 residents received the Pfizer jab, 169,000 received the AstraZeneca vaccine, and 73,000 received the Sputnik.
The results of clinical trials suggest that the Pfizer vaccine is most effective in preventing hospitalization and death from Covid.
However, experts warn that these numbers may not be comparable if other factors can influence their effects, and if the jabs are served on a plate in the real world. increase.
Of the 3,000 AstraZeneca recipients included in the study that captured Covid, only 45 (1.52 percent) were hospitalized and only one (0.03 percent) died from the virus.
Of the 2,000 Pfizer recipients infected with the virus, 40 were hospitalized (1.99%) and 3 died from the virus (0.15%).
Of the 3,000 Sputnik recipients infected with the virus, 77 were hospitalized (2.24%) and 3 died (0.09%).
In the case of the Sinopharm vaccine, there were 24,000 cases, of which 1,683 were hospitalized (6.94%) and 112 died (0.46%).
Of those unvaccinated, about 65,000 were infected with the virus, of which about 9,000 were hospitalized (13.22%) and 857 died (1.32%).
More than 1.5 million people have been vaccinated with US-made Moderna vaccine in the United Kingdom, which is not included in the study.
The AstraZeneca vaccine has a hospitalization rate of only 1.52% and is ideal for keeping people away from the hospital.
SourceThe AstraZeneca vaccine has a hospitalization rate of only 1.52% and is ideal for keeping people away from the hospital.